Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Related: Shannon Miller on Her Ovarian Cancer Diagnosis. The Early Ovarian Cancer Sign Most People Miss. According to experts ...

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.